PANZYGA

This brand name is authorized in United States. It is also authorized in Austria, Canada, Ecuador, Estonia, Ireland, Lithuania, Malta, Netherlands, Poland, Romania, Spain, UK.

Active ingredients

The drug PANZYGA contains one active pharmaceutical ingredient (API):

1	Human normal immunoglobulin G UNII 66Y330CJHS - HUMAN IMMUNOGLOBULIN G
	Human normal immunoglobulin contains mainly immunoglobulin G (IgG) with a broad spectrum of antibodies against infectious agents. Human normal immunoglobulin contains the IgG antibodies present in the normal population. It is usually prepared from pooled plasma from not fewer than 1000 donors.
	Read more about Human normal immunoglobulin G

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PANZYGA Solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J06BA02	Immunoglobulins, normal human, for intravascular adm.	J Antiinfectives for systemic use → J06 Immune sera and immunoglobulins → J06B Immunoglobulins → J06BA Immunoglobulins, normal human
Discover more medicines within J06BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02456087
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	188-MBE-0421
EE	Ravimiamet	1683604, 1683615, 1683626, 1683637, 1683648, 1683659, 1683660, 1683671, 1683682
ES	Centro de información online de medicamentos de la AEMPS	81045
GB	Medicines & Healthcare Products Regulatory Agency	353796, 353801, 353805
LT	Valstybinė vaistų kontrolės tarnyba	1076348, 1080159, 1080160, 1080161, 1080162, 1080163, 1080164, 1080165, 1080166
MT	Medicines Authority	MA1219/00501, MA1219/00502, MA1219/00503, MA1219/00504, MA1219/00505, MA1219/00506, MA1219/00507
NL	Z-Index G-Standaard, PRK	132063, 80039, 80047, 80055, 80063, 80071, 94242
PL	Rejestru Produktów Leczniczych	100343719
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65358001, W65358002, W65358003, W65358004, W65358005, W65358006, W65358007, W65358008, W65358009
US	FDA, National Drug Code	0069-1011, 0069-1109, 0069-1224, 0069-1312, 0069-1415, 0069-1558, 68982-820